Pharmacological inhibition of the chemokine CCL2 (MCP-1) diminishes liver macrophage infiltration and steatohepatitis in chronic hepatic injury

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Gut

• Publication date

  2011-08-03

• Fields of study

  Medicine

• Identifiers
  DOI 10.1136/gutjnl-2011-300304PMID 21813474
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Non‐alcoholic steatohepatitis: Pathogenesis and novel therapeutic approaches

  2013cited by this paper
• The regulation of T‐cell recruitment to the human liver during acute liver failure

  2013cited by this paper
• Chemokine Receptor CXCR6-Dependent Hepatic NK T Cell Accumulation Promotes Inflammation and Liver Fibrosis

  2013influential reference
• Epidemiology and natural history of patients with NAFLD.

  2013cited by this paper
• Report Title: The burden of liver disease in Europe: a review of available epidemiological data

  2013cited by this paper
• Pathophysiology of NASH: perspectives for a targeted treatment.

  2013influential reference
• Liver Fibrosis – Mouse Models and Relevance in Human Liver Diseases

  2013cited by this paper
• Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace.

  2012cited by this paper
• NKT-associated hedgehog and osteopontin drive fibrogenesis in non-alcoholic fatty liver disease

  2012cited by this paper
• Lack of CC chemokine ligand 2 differentially affects inflammation and fibrosis according to the genetic background in a murine model of steatohepatitis

  2012cited by this paper
• Functional role of intrahepatic monocyte subsets for the progression of liver inflammation and liver fibrosis in vivo

  2012cited by this paper
• Liver Transplantation for Nonalcoholic Steatohepatitis: The New Epidemic

  2012cited by this paper
• NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma

  2011cited by this paper
• SR-PSOX/CXCL16 plays a critical role in the progression of colonic inflammation

  2011cited by this paper
• Histopathological diagnosis of non-alcoholic and alcoholic fatty liver disease

  2011cited by this paper
• Modification of chemokine pathways and immune cell infiltration as a novel therapeutic approach in liver inflammation and fibrosis.

  2011cited by this paper
• CD1d-restricted natural killer T cells contribute to hepatic inflammation and fibrogenesis in mice.

  2011cited by this paper
• Accelerated liver fibrosis in hepatitis B virus transgenic mice: Involvement of natural killer T cells

  2011cited by this paper
• C-C chemokine receptor 2 inhibitor improves diet-induced development of insulin resistance and hepatic steatosis in mice.

  2010cited by this paper
• Kupffer cells promote hepatic steatosis via interleukin-1beta-dependent suppression of peroxisome proliferator-activated receptor alpha activity

  2010cited by this paper
• Monocyte chemoattractant protein-1-deficiency does not affect steatosis or inflammation in livers of mice fed a methionine-choline-deficient diet

  2010cited by this paper
• Cardiovascular , Pulmonary and Renal Pathology Late Onset of Ccl 2 Blockade with the Spiegelmer mNOX-E 36 – 3 PEG Prevents Glomerulosclerosis and Improves Glomerular Filtration Rate in db / db Mice

  2010cited by this paper
• Kupffer cells promote hepatic steatosis via interleukin‐1β–dependent suppression of peroxisome proliferator‐activated receptor α activity

  2010cited by this paper
• Functional Contribution of Elevated Circulating and Hepatic Non-Classical CD14+CD16+ Monocytes to Inflammation and Human Liver Fibrosis

  2010cited by this paper
• Epidemiology of Non-Alcoholic Fatty Liver Disease

  2010cited by this paper
• Chemokines in Liver Inflammation and Fibrosis

  2010cited by this paper
• The fractalkine receptor CX3CR1 protects against liver fibrosis by controlling differentiation and survival of infiltrating hepatic monocytes

  2010cited by this paper
• CCR2 mediates hematopoietic stem and progenitor cell trafficking to sites of inflammation in mice.

  2010cited by this paper
• Accumulation of natural killer T cells in progressive nonalcoholic fatty liver disease

  2010cited by this paper
• CX3CL1‐CX3CR1 interaction prevents carbon tetrachloride‐induced liver inflammation and fibrosis in mice

  2010cited by this paper
• Monocytes and macrophages as cellular targets in liver fibrosis.

  2009influential reference
• CXCL16 is expressed in podocytes and acts as a scavenger receptor for oxidized low-density lipoprotein.

  2009cited by this paper
• CCR2 promotes hepatic fibrosis in mice

  2009cited by this paper
• CXCL16 and oxLDL are induced in the onset of diabetic nephropathy

  2009cited by this paper
• Dual role of CCR2 in the constitution and the resolution of liver fibrosis in mice.

  2009cited by this paper
• Hepatic recruitment of the inflammatory Gr1+ monocyte subset upon liver injury promotes hepatic fibrosis

  2009cited by this paper
• Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis.

  2009cited by this paper
• The rtA194T polymerase mutation impacts viral replication and susceptibility to tenofovir in hepatitis B e antigen–positive and hepatitis B e antigen–negative hepatitis B virus strains

  2009cited by this paper
• Anti-Ccl2 Spiegelmer Permits 75% Dose Reduction of Cyclophosphamide to Control Diffuse Proliferative Lupus Nephritis and Pneumonitis in MRL-Fas(lpr) Mice

  2009influential reference
• Diverse roles of invariant natural killer T cells in liver injury and fibrosis induced by carbon tetrachloride

  2009cited by this paper
• Inflammatory Pathways in Liver Homeostasis and Liver Injury

  2009cited by this paper
• Hepatocyte‐specific inhibitor‐of‐kappaB‐kinase deletion triggers the innate immune response and promotes earlier cell proliferation during liver regeneration

  2008cited by this paper
• Late onset of Ccl2 blockade with the Spiegelmer mNOX-E36-3'PEG prevents glomerulosclerosis and improves glomerular filtration rate in db/db mice.

  2008cited by this paper
• Critical Role for the Chemokine Receptor CXCR6 in Homeostasis and Activation of CD1d-Restricted NKT Cells1

  2008cited by this paper
• Homocysteine up-regulates vascular transmembrane chemokine CXCL16 and induces CXCR6+ lymphocyte recruitment in vitro and in vivo

  2008cited by this paper
• Chemokine-directed immune cell infiltration in acute and chronic liver disease

  2008cited by this paper
• TLR4 enhances TGF-β signaling and hepatic fibrosis

  2007cited by this paper
• Spiegelmer inhibition of CCL2/MCP-1 ameliorates lupus nephritis in MRL-(Fas)lpr mice.

  2007cited by this paper
• TLR4 enhances TGF-beta signaling and hepatic fibrosis.

  2007cited by this paper
• Critical roles for CCR2 and MCP-3 in monocyte mobilization from bone marrow and recruitment to inflammatory sites.

  2007cited by this paper
• Monocyte subsets differentially employ CCR2, CCR5, and CX3CR1 to accumulate within atherosclerotic plaques.

  2007cited by this paper
• The biology of NKT cells.

  2007cited by this paper
• Critical Role for CXC Chemokine Ligand 16 (SR-PSOX) in Th1 Response Mediated by NKT Cells1

  2007cited by this paper
• MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity.

  2006cited by this paper
• Monocyte emigration from bone marrow during bacterial infection requires signals mediated by chemokine receptor CCR2

  2006cited by this paper
• Migratory fate and differentiation of blood monocyte subsets.

  2006cited by this paper
• CCR2 modulates inflammatory and metabolic effects of high-fat feeding.

  2006cited by this paper
• Systemic inflammation in nonalcoholic fatty liver disease is characterized by elevated levels of CCL2.

  2006cited by this paper
• Mouse models in non‐alcoholic fatty liver disease and steatohepatitis research

  2006cited by this paper
• Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair.

  2005cited by this paper
• Suppression of macrophage infiltration inhibits activation of hepatic stellate cells and liver fibrogenesis in rats.

  2005cited by this paper
• Intravascular Immune Surveillance by CXCR6+ NKT Cells Patrolling Liver Sinusoids

  2005cited by this paper
• Design and validation of a histological scoring system for nonalcoholic fatty liver disease

  2005cited by this paper
• CXCL16 participates in pathogenesis of immunological liver injury by regulating T lymphocyte infiltration in liver tissue.

  2005cited by this paper
• Liver fibrosis.

  2005cited by this paper
• Tumour necrosis factor α signalling through activation of Kupffer cells plays an essential role in liver fibrosis of non-alcoholic steatohepatitis in mice

  2005cited by this paper
• NKT cells: what's in a name?

  2004influential reference
• Liver fibrosis

  2004cited by this paper
• The intraperitoneal delivery of radiolabeled monoclonal antibodies: studies on the regional delivery advantage

  2004cited by this paper
• Inflammation: the link between insulin resistance, obesity and diabetes.

  2004cited by this paper
• Biodistribution of radiolabeled monoclonal antibody after intraperitoneal administration in nude mice with hepatic metastasis from human colon cancer

  2004cited by this paper
• Liver-infiltrating lymphocytes in end-stage hepatitis C virus: subsets, activation status, and chemokine receptor phenotypes.

  2003cited by this paper
• Prognosis of patients with a diagnosis of fatty liver--a registry-based cohort study.

  2003influential reference
• In vivo properties of an anti-GnRH Spiegelmer: An example of an oligonucleotide-based therapeutic substance class

  2002cited by this paper
• Increased expression of monocyte chemotactic protein-1 during active hepatic fibrogenesis: correlation with monocyte infiltration.

  1998cited by this paper
• Mirror-image RNA that binds D-adenosine

  1996cited by this paper
• Effect of intraperitoneal injection volume and antibody protein dose on the pharmacokinetics of intraperitoneally administered IgG2a kappa murine monoclonal antibody in the rat.

  1991cited by this paper
• Biodistribution of antibodies after intraperitoneal or intravenous injection and effect of carbohydrate modifications.

  1987cited by this paper

• Immune System and Hepatic Stellate Cells’ Crosstalk in Liver Fibrosis: Pathways and Therapeutic Potential

  2026cites this paper
• Single cell RNA sequencing analysis and molecular biology experiments identify NAFLD-related fibroblasts and highlights seven hub genes in NAFLD

  2026cites this paper
• Gut commensal Clostridium sporogenes-derived 5-aminovaleric acid attenuates liver injury by suppressing M1 macrophage activation in mice.

  2026cites this paper
• Hepatocyte–hepatic stellate cell interactions in liver fibrosis: Mechanisms and therapeutic implications

  2026cites this paper
• Targeting the PI3K/AKT signaling pathway: an important molecular mechanism of herbal medicine in the treatment of MASLD/MASH

  2026cites this paper
• Tofogliflozin attenuates liver steatosis and fibrosis in non-diabetic non-alcoholic steatohepatitis mice

  2026cites this paper
• PAD4+ neutrophils promote hepatic stellate cell activation and accelerate MASH fibrosis progression viaNET-DNA/TAOK1/MAPK pathways

  2026cites this paper
• Lacticaseibacillus rhamnosus and Limosilactobacillus reuteri probiotics modulate inflammation, attenuating chronic stress-induced liver injury and behavior in rats.

  2025cites this paper
• Extracellular vesicles from mesenchymal stem cells improve liver injury in rats with mild liver damage. Underlying mechanisms and role of TGFβ.

  2025cites this paper
• Arginine Metabolism Reprogramming in Perfluorooctanoic Acid (PFOA)-Induced Liver Injury.

  2025cites this paper
• Real-ambient PM2.5 exposure disrupts hematopoietic homeostasis via HIF-1α-driven myeloid skewing and promotes organ inflammation

  2025cites this paper
• Vitamin D3 attenuates hepatic inflammation in primary biliary cholangitis by inhibiting TLR4/NF-κB mediated M1 macrophage polarization

  2025cites this paper
• Reversed role of CD36 deficiency in high-fat diet or methionine/choline-deficient diet-induced hepatic steatosis and steatohepatitis

  2025cites this paper
• Liver Fibrosis: Interactions Between Cells and Microenvironments

  2025cites this paper
• OLFML3 Promotes IRG1 Mitochondrial Localization and Modulates Mitochondrial Function in Macrophages

  2025cites this paper
• Elevated miR-34a induced by lipotoxicity and inflammation mediates pathophysiological communication between hepatocytes and hepatic stellate cells in liver fibrosis

  2025cites this paper
• Integrated transcriptomic and proteomic profiling reveals the anti-inflammatory mechanism of dihydroartemisinin in the treatment of acute liver injury by targeting CYBA and CYBB.

  2025cites this paper
• The chemokine CCL20 promotes hepatocyte cholesterol deposition during metabolic dysfunction-associated steatohepatitis by regulating OLR1 expression.

  2025cites this paper
• Regulation of m6A methylation in the immune microenvironment in the development of diabetes mellitus

  2025cites this paper
• The relationship between multiple plasma biomarker levels and renal disease activity in Fabry disease

  2025cites this paper
• METTLING in the pathogenesis of metabolic dysfunction-associated steatotic liver disease.

  2025cites this paper
• Metabolism of hepatic stellate cells in chronic liver diseases: emerging molecular and therapeutic interventions

  2025cites this paper
• Unveiling the Role of Sdc4+ Monocytes in NASH: A Single-Cell RNA Sequencing Study

  2025cites this paper
• Chemokine (C-C Motif) Ligand 2/CCR2/Extracellular Signal-Regulated Kinase Signal Induced through Cancer Cell–Macrophage Interaction Contributes to Hepatocellular Carcinoma Progression

  2025cites this paper
• EGF receptor in organ development, tissue homeostasis and regeneration

  2025cites this paper
• Bone marrow-derived CD169+ macrophages promote autoimmune hepatitis by recruiting CCR2+ monocytes via secreting CCL12

  2025cites this paper
• Regulation of hepatic Sirt1 expression and lipid metabolism through TNF receptor signaling

  2025cites this paper
• The Cardiohepatic Axis in Metabolic Disease

  2025cites this paper
• The heterogeneity of monocyte-derived macrophages in MASH pathogenesis

  2025cites this paper
• Current Therapeutic Landscape for Metabolic Dysfunction-Associated Steatohepatitis

  2025cites this paper
• Plasma hepcidin level is elevated by water immersion‐induced central fatigue via hepatic inflammatory response in male and female rats

  2025cites this paper
• The Intriguing Roles of Cytokines in Metabolic Dysfunction-Associated Steatotic Liver Disease: A Narrative Review

  2025cites this paper
• Low Hepatic CEACAM1 Tethers Metabolic Dysfunction Steatohepatitis to Atherosclerosis

  2025cites this paper
• Type I IFN receptor blockade alleviates liver fibrosis through macrophage-derived STAT3 signaling

  2025cites this paper
• A new insight: crosstalk between neutrophil extracellular traps and the gut-liver axis for nonalcoholic fatty liver disease

  2025cites this paper
• The spatial and temporal activation of macrophages during fibrosis

  2025cites this paper
• Post-translational modifications in the pathophysiological process of metabolic dysfunction‑associated steatotic liver disease

  2025cites this paper
• Macrophage Signaling Pathways in Health and Disease: From Bench to Bedside Applications

  2025cites this paper
• 2,5-Dihydroxybenzoic Acid Ameliorates Metabolic Dysfunction-Associated Steatotic Liver Disease by Targeting the CCL2-CCR2 Axis to Reduce Lipid Accumulation

  2025cites this paper
• Knowledge landscape of macrophage research in liver fibrosis: a bibliometric review of the literature from WoSCC

  2025cites this paper
• Inflammation in MASLD progression and cancer

  2025cites this paper
• Modification of MSCs with aHSCs-targeting peptide pPB for enhanced therapeutic efficacy in liver fibrosis.

  2025cites this paper
• Inhibiting peripheral serotonin activates liver AMPK and reduces monocyte-derived macrophages and fibrosis.

  2025cites this paper
• Mechanistic Insights into the Role of MCP-1 in Diverse Liver Pathological Conditions: A Recent Update.

  2025cites this paper
• Inhibition of chemokine MCP-1 with mNOX-E36 reduces scarring in a mouse model of glaucoma filtration surgery.

  2025cites this paper
• Integrated bulk and single-cell transcriptomics identify RELB, S100A9, and SOCS1 as key autophagy-endoplasmic reticulum stress genes linking T2DM with MAFLD

  2025cites this paper
• Relation between monocyte to high-density lipoprotein cholesterol ratio and prognosis in recipients after liver transplantation.

  2025cites this paper
• Multiple cell-type interactions drive invariant NKT cell hepatitis

  2025cites this paper
• Myeloid cells in chronic liver inflammation

  2025cites this paper
• RANTES, IP-10 and MCP-1 Profiles in Patients with Autoimmune Hepatitis (AIH) at Baseline and During Immunosuppressive Treatment

  2025cites this paper
• Immune Checkpoints and the Immunology of Liver Fibrosis

  2025cites this paper
• Key role of macrophages in the progression of hepatic fibrosis

  2024cites this paper
• The Evolving Role of Neutrophils and Neutrophil Extracellular Traps (NETs) in Obesity and Related Diseases: Recent Insights and Advances

  2024cites this paper
• Wnt5a promotes Kupffer cell activation in trichloroethylene-induced immune liver injury

  2024cites this paper
• The Multifaced Roles of Hepatic Macrophages in MASLD

  2024cites this paper
• The Role of Macrophages in Hepatocellular Carcinoma and Their Therapeutic Potential

  2024cites this paper
• Platelet-rich plasma-derived extracellular vesicles improve liver cirrhosis in mice

  2024cites this paper
• Unveiling the nexus: pyroptosis and its crucial implications in liver diseases

  2024cites this paper
• Potential diagnostic markers and therapeutic targets for non-alcoholic fatty liver disease and ulcerative colitis based on bioinformatics analysis and machine learning

  2024cites this paper
• Alleviation of Alcoholic Liver Injury through Composite Postbiotics Regulation of Intestinal Flora and Promotion of Bile Acid Metabolism

  2024cites this paper
• Chinese herbal formula in the treatment of metabolic dysfunction-associated steatotic liver disease: current evidence and practice

  2024cites this paper
• Elevated Porcupine Disrupts Lipid Metabolism and Promotes Inflammatory Response in MASLD

  2024cites this paper
• Apoptotic vesicles (apoVs) derived from fibroblast-converted hepatocyte-like cells effectively ameliorate liver fibrosis

  2024cites this paper
• A Genetically Engineered Biomimetic Nanodecoy for the Treatment of Liver Fibrosis

  2024cites this paper
• Active role of the immune system in metabolic dysfunction-associated steatotic liver disease

  2024cites this paper
• Causal relationship between key genes and metabolic dysfunction‐associated fatty liver disease risk mediated by immune cells: A Mendelian randomization and mediation analysis

  2024cites this paper
• The methyltransferase MLL4 promotes nonalcoholic steatohepatitis by enhancing NF-κB signaling

  2024cites this paper
• The Gut-Liver Axis in NAFLD Progression: Insights into Pathogenesis and Therapeutic Opportunities

  2024cites this paper
• Helicobacter pylori and metabolic syndrome‐related adipokines in nonalcoholic fatty liver disease pathophysiology

  2024cites this paper
• Cenicriviroc suppresses and reverses steatohepatitis by regulating macrophage infiltration and M2 polarization in mice.

  2024cites this paper
• Liver fibrosis pathologies and potentials of RNA based therapeutics modalities

  2024cites this paper
• Role of Macrophages in Liver Fibrosis.

  2024cites this paper
• Anti-inflammatory mechanisms of neutrophil membrane-coated nanoparticles without drug loading.

  2024cites this paper
• Interleukin-6 trans-signaling regulates monocyte chemoattractant protein-1 production in immune-mediated necrotizing myopathy.

  2024cites this paper
• Glycyrrhizic acid alleviates concanavalin A-induced acute liver injury by regulating monocyte-derived macrophages.

  2024cites this paper
• Diverse potential of secretome from natural killer cells and monocyte-derived macrophages in activating stellate cells

  2024cites this paper
• Renal macrophages and NLRP3 inflammasomes in kidney diseases and therapeutics

  2024cites this paper
• Single-cell transcriptomics reveal the microenvironment landscape of perfluorooctane sulfonate-induced liver injury in female mice.

  2024cites this paper
• RNA-seq combined network pharmacology reveals that Fu-Gan-Wan (FGW) inhibits liver fibrosis via NF-κB/CCL2/CCR2 and lipid peroxidation via Nrf2/HMOX1 signaling pathway.

  2024cites this paper
• Advancements of Macrophages Involvement in Pathological Progression of Colitis-Associated Colorectal Cancer and Associated Pharmacological Interventions

  2024cites this paper
• Liver Fibrosis: From Basic Science towards Clinical Progress, Focusing on the Central Role of Hepatic Stellate Cells

  2024cites this paper
• Inhibition of intrahepatic monocyte recruitment by Cenicriviroc and extracellular matrix degradation by MMP1 synergistically attenuate liver inflammation and fibrogenesis in vivo

  2024cites this paper
• Choroid plexus CCL2‒CCR2 signaling orchestrates macrophage recruitment and cerebrospinal fluid hypersecretion in hydrocephalus

  2024cites this paper
• Circulating Monocyte Chemoattractant Protein-1 (MCP-1) in Patients with Primary Biliary Cholangitis

  2024cites this paper
• Survivin inhibition ameliorates liver fibrosis by inducing hepatic stellate cell senescence and depleting hepatic macrophage population

  2024cites this paper
• Sphingosine Kinase 1 Aggravates Liver Fibrosis by Mediating Macrophage Recruitment and Polarization

  2024cites this paper
• Oxytocin alleviates liver fibrosis via hepatic macrophages

  2024cites this paper
• The role of N6-methyladenosine in macrophage polarization: A novel treatment strategy for non-alcoholic steatohepatitis.

  2024cites this paper
• Exploring the Mechanism of Action of Silybum Marianum against Liver Fibrosis Based on Network Pharmacology

  2024cites this paper
• Kupffer cells abrogate homing and repopulation of allogeneic hepatic progenitors in injured liver site

  2024cites this paper
• The role of macrophages in liver fibrosis: composition, heterogeneity, and therapeutic strategies

  2024cites this paper
• A liver digital twin for in silico testing of cellular and inter-cellular mechanisms in regeneration after drug-induced damage

  2023influential citation
• Alanyl-Glutamine Dipeptide Attenuates Non-Alcoholic Fatty Liver Disease Induced by a High-Fat Diet in Mice by Improving Gut Microbiota Dysbiosis

  2023cites this paper
• Monocyte-derived macrophages contribute to the deterioration of immunological liver injury in mice.

  2023cites this paper
• A natural Nrf2 activator glucoraphanin improves hepatic steatosis in high-fat diet-induced obese male mice associated with AMPK activation

  2023cites this paper
• Smart antioxidant function enhancing (SAFE) nucleic acid therapy for ROS-related chronic diseases and comorbidities

  2023cites this paper
• Global Trends of Treatment for NAFLD from 2012 to 2021: A Bibliometric and Mapping Analysis.

  2023cites this paper
• YKL-40 promotes chemokine expression following drug-induced liver injury via TF-PAR1 pathway in mice

  2023cites this paper
• Garlic-derived exosome-like nanovesicles as a hepatoprotective agent alleviating acute liver failure by inhibiting CCR2/CCR5 signaling and inflammation.

  2023cites this paper
• Mechanism of immune attack in the progression of obesity-related type 2 diabetes

  2023cites this paper